{
  "context": {
    "rules": [
      "Rule1: If medication X receives regulatory approval, then it is quality certified.",
      "Rule2: Under the condition that medication X undergoes batch testing, if it is quality certified, then market release occurs.",
      "Rule3: Either medication X undergoes batch testing or it undergoes accelerated review.",
      "Rule4: In the event that medication X undergoes accelerated review, then if it is quality certified, market release follows.",
      "Rule5: Whenever medication X passes trials, it is approved.",
      "Rule6: Provided that medication X passes inspection, the pharmaceutical company is profitable.",
      "Rule7: If medication X is authorized for emergency use, then it is not contaminated.",
      "Rule8: Either medication X has safety issues or it is authorized for emergency use.",
      "Rule9: Under the condition that medication X has an alternative formula, it does not have safety issues.",
      "Rule10: Medication X has an alternative formula or it is reformulated.",
      "Rule11: In the event that medication X is reformulated, it does not have safety issues.",
      "Rule12: If it is not the case that medication X passes trials or passes inspection, then it is contaminated.",
      "Rule13: Provided that it is not the case that medication X undergoes clinical trials or does not have safety issues, regulatory approval follows."
    ],
    "facts": [
      "Fact1: Medication X is not approved.",
      "Fact2: Medication X does not have market release.",
      "Fact3: Medication X does not undergo clinical trials."
    ]
  },
  "question": "The pharmaceutical company is profitable."
}